• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝癌——第1部分:组织病理学、鉴别诊断及风险分层

Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.

作者信息

Jiang Kun, Al-Diffhala Sameer, Centeno Barbara A

机构信息

1 Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

2 Department of Oncologic Sciences, Morsani College of Medicine at University of South Florida, Tampa, FL, USA.

出版信息

Cancer Control. 2018 Jan-Mar;25(1):1073274817744625. doi: 10.1177/1073274817744625.

DOI:10.1177/1073274817744625
PMID:29350068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5933592/
Abstract

Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) are the 2 most common primary malignant liver tumors, with hepatocellular and bile ductular differentiation, respectively. This article reviews the key histopathological findings of these 2 primary liver cancers and includes a review of the role of ancillary testing for differential diagnosis, risk stratification according to the American Joint Committee on Cancer (AJCC) staging recommendation, and a review of precancerous lesions. A literature review was conducted to identify articles with information relevant to precancerous precursors, current histopathological classification, ancillary testing, and risk stratification of primary malignant liver tumors. The histomorphology of normal liver, preinvasive precursors, primary malignancies, and morphological variants, and the utilization of ancillary tests for the pathological diagnosis are described. Dysplastic nodules are the preinvasive precursors of HCC, and intraductal papillary neoplasms of bile ducts and biliary intraepithelial neoplasia are the preinvasive precursors of CC. Benign liver nodules including focal nodular hyperplasia and adenomas are included in this review, since some forms of adenomas progress to HCC and often they have to be differentiated from well-differentiated HCC. A number of morphological variants of HCC have been described in the literature, and it is necessary to be aware of them in order to render the correct diagnosis. Risk stratification is still dependent on the AJCC staging system. The diagnosis of primary liver carcinomas is usually straightforward. Application of the appropriate ancillary studies aids in the differential diagnosis of difficult cases. The understanding of the carcinogenesis of these malignancies has improved with the standardization of the pathological classification of preinvasive precursors and studies of the molecular pathogenesis. Risk stratification still depends on pathological staging.

摘要

肝细胞癌(HCC)和胆管癌(CC)是两种最常见的原发性恶性肝肿瘤,分别具有肝细胞和胆管上皮分化。本文回顾了这两种原发性肝癌的关键组织病理学发现,包括辅助检测在鉴别诊断中的作用、根据美国癌症联合委员会(AJCC)分期建议进行风险分层,以及对癌前病变的回顾。进行了文献综述,以确定与原发性恶性肝肿瘤的癌前病变、当前组织病理学分类、辅助检测和风险分层相关信息的文章。描述了正常肝脏、浸润前病变、原发性恶性肿瘤和形态学变异的组织形态学,以及辅助检测在病理诊断中的应用。发育异常结节是HCC的浸润前病变,胆管内乳头状肿瘤和胆管上皮内瘤变是CC的浸润前病变。本综述包括良性肝结节,如局灶性结节性增生和腺瘤,因为某些形式的腺瘤会进展为HCC,并且它们常常需要与高分化HCC进行鉴别。文献中描述了许多HCC的形态学变异,为了做出正确诊断,有必要了解它们。风险分层仍然依赖于AJCC分期系统。原发性肝癌的诊断通常很直接。应用适当的辅助检查有助于疑难病例的鉴别诊断。随着浸润前病变病理分类的标准化和分子发病机制的研究,对这些恶性肿瘤发生机制的理解有了提高。风险分层仍然依赖于病理分期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/b9e2eaaa4332/10.1177_1073274817744625-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/bca518f8ccab/10.1177_1073274817744625-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/0529f304c0a3/10.1177_1073274817744625-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/07eb491bed98/10.1177_1073274817744625-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/17b04a392645/10.1177_1073274817744625-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/26c51b01288c/10.1177_1073274817744625-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/a03841af28e2/10.1177_1073274817744625-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/9058c64da337/10.1177_1073274817744625-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/a5c9048cbe1f/10.1177_1073274817744625-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/f11ddbe2f482/10.1177_1073274817744625-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/85d4818b2bd2/10.1177_1073274817744625-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/f539bd469c2b/10.1177_1073274817744625-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/03512035ff37/10.1177_1073274817744625-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/b9e2eaaa4332/10.1177_1073274817744625-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/bca518f8ccab/10.1177_1073274817744625-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/0529f304c0a3/10.1177_1073274817744625-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/07eb491bed98/10.1177_1073274817744625-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/17b04a392645/10.1177_1073274817744625-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/26c51b01288c/10.1177_1073274817744625-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/a03841af28e2/10.1177_1073274817744625-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/9058c64da337/10.1177_1073274817744625-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/a5c9048cbe1f/10.1177_1073274817744625-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/f11ddbe2f482/10.1177_1073274817744625-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/85d4818b2bd2/10.1177_1073274817744625-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/f539bd469c2b/10.1177_1073274817744625-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/03512035ff37/10.1177_1073274817744625-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8515/5933592/b9e2eaaa4332/10.1177_1073274817744625-fig13.jpg

相似文献

1
Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.原发性肝癌——第1部分:组织病理学、鉴别诊断及风险分层
Cancer Control. 2018 Jan-Mar;25(1):1073274817744625. doi: 10.1177/1073274817744625.
2
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].[肝细胞癌和胆管癌——不同的预后、发病机制及治疗]
Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195.
3
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice.肝脏的癌前病变:分子见解及其在临床实践中的相关性。
Liver Int. 2022 Mar;42(3):492-506. doi: 10.1111/liv.15152. Epub 2022 Jan 17.
4
Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.原发性肝癌,第2部分:进展途径与致癌作用
Cancer Control. 2018 Jan-Mar;25(1):1073274817744658. doi: 10.1177/1073274817744658.
5
[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].[硫酸乙酰肝素蛋白聚糖在肝细胞癌微血管中的选择性沉积:发病机制及鉴别诊断方面]
Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7.
6
The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.αvβ6 整联蛋白是胆管癌的高度特异性免疫组化标志物。
J Hepatol. 2010 Mar;52(3):362-9. doi: 10.1016/j.jhep.2009.12.006. Epub 2010 Jan 13.
7
Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.起源于两个不同发育异常结节的同步性肝细胞癌和胆管癌。
Mod Pathol. 2002 Oct;15(10):1096-101. doi: 10.1097/01.MP.0000027622.74779.AE.
8
Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.肝细胞癌及肝细胞结节性病变的细针穿刺活检:作用、争议及诊断方法
Cytopathology. 2011 Oct;22(5):287-305. doi: 10.1111/j.1365-2303.2011.00882.x. Epub 2011 Jul 18.
9
Evaluating Liver Biopsies with Well-Differentiated Hepatocellular Lesions.评估分化良好的肝细胞性病变的肝活检。
Surg Pathol Clin. 2023 Sep;16(3):581-598. doi: 10.1016/j.path.2023.04.011. Epub 2023 Jun 9.
10
Hepatic adenoma and focal nodular hyperplasia.肝腺瘤和局灶性结节性增生。
Surg Gynecol Obstet. 1991 Nov;173(5):426-31.

引用本文的文献

1
Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheres.基于体素的比较剂量测定法:使用预处理的Tc-99m单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)和治疗后的钇-90正电子发射断层扫描/磁共振成像(Y-90 PET/MRI)对钇-90微球放射性栓塞进行研究
Ann Nucl Med. 2025 Jul;39(7):716-731. doi: 10.1007/s12149-025-02052-5. Epub 2025 Apr 23.
2
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database.早发性肝癌和肝内胆管癌发病率上升:国家儿童癌症登记数据库分析
Cancers (Basel). 2025 Mar 28;17(7):1133. doi: 10.3390/cancers17071133.
3

本文引用的文献

1
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
2
Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.健康肝脏的良性肝细胞结节:局灶性结节性增生和肝细胞腺瘤。
Clin Mol Hepatol. 2016 Jun;22(2):199-211. doi: 10.3350/cmh.2016.0101. Epub 2016 May 18.
3
Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor.
肝细胞癌合并胆管癌中的肉瘤样改变作为一个预后不良因素。
J Gastrointest Oncol. 2024 Aug 31;15(4):1796-1804. doi: 10.21037/jgo-24-313. Epub 2024 Aug 22.
4
Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.天然抗氧化剂的纳米制剂治疗肝癌。
Biomolecules. 2024 Aug 19;14(8):1031. doi: 10.3390/biom14081031.
5
Transcription factor targets to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling.转录因子靶标通过甘氨酸炎症小体信号抑制肝细胞癌的进展。
Biomol Biomed. 2024 Oct 17;24(6):1606-1619. doi: 10.17305/bb.2024.10328.
6
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.关于在肝内胆管癌患者管理中最大化组织临床价值的建议。
JHEP Rep. 2024 Mar 12;6(6):101067. doi: 10.1016/j.jhepr.2024.101067. eCollection 2024 Jun.
7
RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma.RIT1 通过与 SMC3 和 PDS5 在肝癌中相互作用来调节有丝分裂并促进增殖。
J Exp Clin Cancer Res. 2023 Nov 29;42(1):326. doi: 10.1186/s13046-023-02892-x.
8
Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice.重组腺相关病毒的基因组设计导致小鼠肝脏和脾脏的病理变化。
Adv Cell Gene Ther. 2022;2022. doi: 10.1155/2022/6807904. Epub 2022 Mar 20.
9
Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis.组织相容性 13 高表达与肝癌的发生发展及预后相关。
Genet Res (Camb). 2022 Oct 3;2022:7067743. doi: 10.1155/2022/7067743. eCollection 2022.
10
MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.肝细胞癌组织学亚型的 MRI 特征:与组织学、遗传学和分子生物学分类的相关性。
Eur Radiol. 2022 Aug;32(8):5119-5133. doi: 10.1007/s00330-022-08643-4. Epub 2022 Mar 8.
联合使用热休克蛋白70和谷氨酰胺合成酶有助于鉴别典型肝细胞腺瘤与非典型肝细胞肿瘤以及高分化肝细胞癌。
Mod Pathol. 2016 Mar;29(3):283-92. doi: 10.1038/modpathol.2015.162. Epub 2016 Jan 15.
4
Immunohistochemical evaluation of a sarcomatoid hepatocellular carcinoma with osteoclastlike giant cells.伴有破骨细胞样巨细胞的肉瘤样肝细胞癌的免疫组织化学评估
Diagn Pathol. 2015 Apr 28;10:40. doi: 10.1186/s13000-015-0274-4.
5
Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature.肉瘤样肝细胞-胆管细胞癌合并症:一例报告及文献综述
Int J Clin Exp Pathol. 2014 Oct 15;7(11):8290-4. eCollection 2014.
6
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.使用新型分支DNA增强白蛋白RNA原位杂交技术明确诊断肝内胆管癌的能力
Ann Surg Oncol. 2016 Jan;23(1):290-6. doi: 10.1245/s10434-014-4247-8. Epub 2014 Dec 18.
7
Advances in fibrolamellar hepatocellular carcinoma: a review.纤维板层型肝细胞癌的研究进展:综述
Eur J Pediatr Surg. 2014 Dec;24(6):461-6. doi: 10.1055/s-0034-1396420. Epub 2014 Dec 8.
8
Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications.胆管上皮内瘤变(BilIN)在胆管癌切除标本的手术切缘中经常发现,但并无临床意义。
Virchows Arch. 2015 Feb;466(2):133-41. doi: 10.1007/s00428-014-1689-0. Epub 2014 Nov 26.
9
Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.表达“干性”相关标志物的肝细胞癌:临床病理特征
Dig Dis. 2014;32(6):778-85. doi: 10.1159/000368021. Epub 2014 Oct 29.
10
Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.维生素B₁₂及其结合蛋白在肝细胞癌和慢性肝病中的研究
Scand J Gastroenterol. 2014 Sep;49(9):1096-102. doi: 10.3109/00365521.2014.921325. Epub 2014 Jun 24.